BlackRock’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

BlackRock’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,922,893	Closed	-$11.7M	–	6115
2022 Q1	$11.7M	Sell	3,922,893 -2,576,809	-40%	-$5.67M	﹤0.01%	3494
2021 Q4	$8.32M	Buy	6,499,702 +263,070	+4%	+$527K	﹤0.01%	3778
2021 Q3	$14.1M	Buy	6,236,632 +712,101	+13%	+$2.56M	﹤0.01%	3504
2021 Q2	$31.4M	Buy	5,524,531 +2,868,298	+108%	+$19.1M	﹤0.01%	3020
2021 Q1	$16.7M	Buy	2,656,233 +31,476	+1%	+$236K	﹤0.01%	3278
2020 Q4	$20.6M	Buy	+2,624,757	New	+$23.2M	﹤0.01%	2992

BlackRock's TLMD Position: Q2 2022 in Review

BlackRock sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 3,922,893 shares — an estimated $11.7M sold.

BlackRock first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $31.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

BlackRock reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
BlackRock sold 3,922,893 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $11.7M.
BlackRock first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
BlackRock's SOC Telemed, Inc. Class A Common Stock position peaked at $31.4M in Q2 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.